Login / Signup

Retraction Note: Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M 2 -GnRH 3 -hinge-MVP vaccine.

Yiqin WangMurad AlahdalJia YeLiangliang JingXiaoxin LiuHuan ChenLiang JinRongyue Cao
Published in: Genes and immunity (2023)
Keyphrases
  • mouse model
  • immune response
  • prostate cancer
  • vascular endothelial growth factor
  • endothelial cells
  • benign prostatic hyperplasia
  • toll like receptor
  • dendritic cells
  • inflammatory response